Dr. Reilmann presents in symposium at MDS 2019 in Nice
Dr. Reilmann (GHI) outlined the opportunities of quantitative endpoints for clinical trials in Huntington's disease at a symposium of the International Parkinson and Movement Disorders Society annual meeting 2019 in Nice, France. He was joined by Dr. Edward Wild, London, UK. Prof. Baas Bloem, Nijmegen, Netherlands, and Prof. Tanya Simuni, Chicago, USA, made the case for Parkinson's disease. A vivid panel discussion stressed the novel opportunities of objective devices. The event was support by an eductional grant of Hoffmann-La Roche.